Mission Wealth Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Mission Wealth Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,661	Closed	-$339K	–	352
2019 Q4	$339K	Sell	5,661 -29,043	-84%	-$1.09M	0.03%	236
2019 Q3	$975K	Sell	34,704 -450	-1%	-$15.4K	0.1%	103
2019 Q2	$1.33M	Hold	35,154	–	–	0.15%	79
2019 Q1	$1.37M	Sell	35,154 -80	-0.2%	-$2.29K	0.16%	77
2018 Q4	$751K	Hold	35,234	–	–	0.1%	106
2018 Q3	$1.4M	Hold	35,234	–	–	0.18%	68
2018 Q2	$1.35M	Sell	35,234 -1,554	-4%	-$57.6K	0.2%	65
2018 Q1	$1.1M	Buy	+36,788	New	+$1.25M	0.18%	68

Mission Wealth Management's BOLD Position: Q1 2020 in Review

Mission Wealth Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 5,661 shares — an estimated $339K sold.

Mission Wealth Management first reported a position in BOLD in Q1 2018 and held it in 8 quarters. The position peaked at $1.4M in Q3 2018. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Mission Wealth Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Mission Wealth Management sold 5,661 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $339K.
Mission Wealth Management first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 8 quarters.
Mission Wealth Management's Audentes Therapeutics, Inc position peaked at $1.4M in Q3 2018.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Mission Wealth Management's 13F filing for Q1 2020, filed 10 Apr 2020.